Company Information
About Sonic Healthcare Limited (ASX: SHL)
Sonic Healthcare Limited is an Australian healthcare provider specializing in laboratory medicine, radiology, and primary care medical services. The company has a presence in Australia, Europe, and North America and is organized into three main segments: Laboratory, Radiology, and Other. The Laboratory segment delivers a wide range of pathology and clinical laboratory services, and has operations in several countries, including Australia, New Zealand, UK, USA, Germany, Switzerland, and Belgium. Radiology services, which are provided only in Australia, cover various diagnostic imaging technologies like MRI, CT, ultrasound, X-ray, and mammography. The Other segment involves operations in medical centers, occupational health services, and additional minor activities.
Sonic Healthcare provides its diagnostic and health services to a client base consisting of medical professionals, hospitals, community health services, and patients. The company has a notable network of over 120 radiology centers.
Financially, Sonic Healthcare reported a total revenue of AUD 8.39 billion with a net income of AUD 504.94 million. Founded in 1934, the company employs approximately 41,000 people. Sonic Healthcare has experienced a revenue decline of 12.54% year on year, slipping from AUD 9.34 billion to AUD 8.17 billion, along with a significant reduction in net income of 53.10%, falling from AUD 1.46 billion to AUD 684.98 million. Factors contributing to this downturn include a drop in revenue and an escalation in selling, general, and administrative expenses.
Top Australian Brokers
- City Index - Aussie shares from $5 - Read our review
- Pepperstone - Trading education - Read our review
- IC Markets - Experienced and highly regulated - Read our review
- eToro - Social and copy trading platform - Read our review
Sonic Healthcare Limited (ASX: SHL) Live Chart
Sonic Healthcare Limited (ASX: SHL) Forecast
Analysts from Wall Street have been examining Sonic Healthcare Limited and provided their projections for the stock’s performance over the next 12 months. On average, they have set a goal price of AU$30.63 for the stock. Their estimates range, with the highest price target at AU$34.00 and the lowest at AU$26.20. If these predictions hold true, it would mean an expected increase of about 11.10% from Sonic Healthcare’s last trading price, which was AU$27.57.
Latest Sonic Healthcare Limited News
Sonic Healthcare Limited (ASX: SHL) Performance
Sonic Healthcare Limited (ASX: SHL) Fundamentals
Sonic Healthcare Limited (ASX: SHL) Competitors
Don’t Buy Just Yet
You will want to see this before you make any decisions.
Before you decide which shares to add to your portfolio you might want to take a look at this special report we recently published.
Our experts picked out The 5 best ASX shares to buy in 2024.
We’re giving away this valuable research for FREE.
Click below to secure your copy
